Here’s whether Guardant Health, Inc. Common Stock (GH) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+10.06% over 10 days); strong 1-year return of +223.9%; 3-month momentum positive (+65.7%). Concerns: declining volume on rally — weak conviction (0.59x 30d avg). Currently 15.4% off its 52-week high. Score: +5/7.
GH is in a confirmed uptrend, trading above both its 50-day ($136.87) and 200-day ($105.17) moving averages. An RSI of 31.0 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +223.9% compares to +16.5% for SPY (beat the market by 207.4%).
$10,000 invested 1 year ago→ $32,387 today
vs. S&P 500 (SPY) — same period beat market by 207.4%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($105.17)
✓Above 50-day MA ($136.87)
✓RSI(14) neutral zone (30–70) — currently 31.0
✓Positive return (+223.9%)
!Within 10% of period high (−15.4%)
Period Range $147.33
$40.36$174.08
RSI (14) 31.0
0 · OversoldOverbought · 100
Key Metrics
Price$147.33
Period Return+223.9%
Period High$174.08
Period Low$40.36
Drawdown−15.4%
MA-50$136.87
MA-200$105.17
RSI (14)31.0
Avg Volume (30d)3.0M
vs. SPYbeat by 207.4%
Return Rank#41 of 999
Trend Signals
Price is above the 200-day moving average ($105.17)
Price is above the 50-day moving average ($136.87)